China Cyts Tours Holding Co., Ltd. (600138.SS) Bundle
Dive into a hard-data assessment of China Cyts Tours Holding Co., Ltd. (600138.SS): Q1 2025 revenue reached 2.054 billion yuan (up 6.84% year-on-year) while trailing twelve months revenue to Sept 30, 2025 totaled 10.94 billion yuan (+9.93% y/y) against a 2024 full-year revenue of 9.96 billion yuan, yet profitability remains tight with a Q1 2025 net loss of 33.7052 million yuan and a TTM net profit margin of 1.17% (EPS 0.18 yuan, ROA 3.73%, ROE 4.32%); balance-sheet metrics show total assets of 17.84 billion yuan, total liabilities of 9.34 billion yuan (up 9.06% y/y), total equity of 8.50 billion yuan and a debt-to-equity ratio of 75.09% while market valuation sits at a market cap of 6.88 billion yuan with a stock price of 9.50 yuan (Dec 17, 2025), enterprise value of 14.27 billion yuan, P/S 0.63, P/B 1.11 and a trailing P/E of 53.26 (forward P/E 11.33); liquidity and cash metrics include cash and short-term investments of 1.37 billion yuan (up 28.10% y/y), current ratio ~1.5 and quick ratio ~1.2, but operational cash flow in Q2 2025 fell to 27.80 million yuan (down 83.42% y/y) and TTM free cash flow is 58.95 million yuan (down 31.97% y/y); watch valuation, dividend (0.7 yuan per 10 shares proposed; yield 0.75%), and growth levers such as inbound R&D, Beijing Wtown development, Wuzhen operations and diversified hotel/IT revenue streams as you read on.
China Cyts Tours Holding Co., Ltd. (600138.SS) - Revenue Analysis
China Cyts Tours reported steady top-line growth through 2024-2025, driven by recovery in travel demand and improved per-employee productivity. Key topline metrics and valuation context are summarized below.- Q1 2025 revenue: 2.054 billion yuan, up 6.84% YoY.
- TTM revenue (as of Sept 30, 2025): 10.94 billion yuan, up 9.93% YoY.
- Full-year 2024 revenue: 9.96 billion yuan, up 3.34% vs. 2023.
- Revenue per employee: ~1.79 million yuan (6,095 employees).
- Price-to-Sales (P/S): 0.63 - indicating a low market valuation relative to sales.
- Market capitalization: 6.88 billion yuan; share price: 9.50 yuan (as of Dec 17, 2025).
| Metric | Value | Period / Date |
|---|---|---|
| Q1 Revenue | 2.054 billion yuan | Q1 2025 |
| Q1 YoY Growth | 6.84% | Q1 2025 vs Q1 2024 |
| TTM Revenue | 10.94 billion yuan | As of 2025-09-30 |
| TTM YoY Growth | 9.93% | TTM vs prior 12 months |
| Annual Revenue | 9.96 billion yuan | 2024 |
| Annual Growth | 3.34% | 2024 vs 2023 |
| Employees | 6,095 | Latest reported |
| Revenue per Employee | ~1.79 million yuan | Calculated |
| Price-to-Sales (P/S) | 0.63 | Market valuation metric |
| Market Capitalization | 6.88 billion yuan | Dec 17, 2025 |
| Share Price | 9.50 yuan | Dec 17, 2025 |
- Sales momentum: TTM growth of 9.93% outpaces 2024 full-year growth (3.34%), indicating acceleration into 2025.
- Productivity: revenue/employee (~1.79M yuan) suggests operational leverage versus peers in the tourism sector.
- Valuation: P/S 0.63 and market cap 6.88B yuan imply modest market expectations relative to sales base.
China Cyts Tours Holding Co., Ltd. (600138.SS) - Profitability Metrics
- Q1 2025 net loss: ¥33.7052 million (vs. Q1 2024 net loss: ¥28.999 million)
- Trailing twelve months (TTM) net profit margin: 1.17%
- TTM earnings per share (EPS): ¥0.18
- Return on assets (ROA): 3.73%
- Return on equity (ROE): 4.32%
- TTM operating income: ¥650 million
- TTM gross profit: ¥2.2 billion
| Metric | Value | Period |
|---|---|---|
| Net (Loss) / Profit | ¥(33.7052) million | Q1 2025 |
| Net (Loss) / Profit | ¥(28.999) million | Q1 2024 |
| Net Profit Margin (TTM) | 1.17% | TTM |
| EPS (TTM) | ¥0.18 | TTM |
| ROA | 3.73% | Latest reported |
| ROE | 4.32% | Latest reported |
| Operating Income (TTM) | ¥650,000,000 | TTM |
| Gross Profit (TTM) | ¥2,200,000,000 | TTM |
- Profitability is thin: a positive TTM margin (1.17%) and EPS (¥0.18) contrast with a recent quarterly net loss, indicating volatility across reporting periods.
- ROA (3.73%) and ROE (4.32%) show modest returns on assets and equity-management is generating limited shareholder value relative to capital employed.
- Discrepancy between TTM operating income (¥650M) and gross profit (¥2.2B) warrants scrutiny of revenue recognition, cost structure, or one-off items in the income statement and footnotes.
China Cyts Tours Holding Co., Ltd. (600138.SS) - Debt vs. Equity Structure
Key balance-sheet metrics as of June 2025 highlight a moderately leveraged profile with meaningful near-term obligations and a valuation slightly above book value.
- Total liabilities: ¥9.34 billion (June 2025), up 9.06% YoY
- Total equity: ¥8.50 billion
- Total assets: ¥17.84 billion
- Debt-to-equity ratio: 75.09%
- Enterprise value (EV): ¥14.27 billion
- Price-to-book (P/B): 1.11
| Metric | Value (¥ billion) | Notes |
|---|---|---|
| Total assets | 17.84 | Assets = Liabilities + Equity |
| Total liabilities | 9.34 | +9.06% YoY (June 2025) |
| Total equity | 8.50 | Book equity reported at period end |
| Debt-to-equity ratio | 75.09% | Moderate leverage |
| Enterprise value (EV) | 14.27 | Higher than market cap (implies net debt included) |
| Price-to-book (P/B) | 1.11 | Shares trade slightly above book value |
- Debt composition: mix of short-term and long-term liabilities, with a significant portion maturing within one year - increases near-term refinancing/ liquidity considerations.
- Leverage interpretation: 75.09% debt-to-equity implies ¥0.75 of liabilities for every ¥1.00 of equity, a level consistent with moderate financial risk for a capital-intensive travel/tour operator.
- Valuation angle: EV (¥14.27bn) > implied market cap - investors should account for net debt when comparing to peers.
For broader investor context and ownership dynamics, see Exploring China Cyts Tours Holding Co., Ltd. Investor Profile: Who's Buying and Why?
China Cyts Tours Holding Co., Ltd. (600138.SS) - Liquidity and Solvency
China Cyts Tours Holding Co., Ltd. (600138.SS) shows mixed short‑term liquidity strength alongside pressured cash generation in recent reporting periods. Key balance sheet and cash‑flow metrics (as of June 2025 and trailing twelve months where noted) highlight available liquid resources, workable current coverage, but declining operational cash conversion.- Cash & short-term investments: 1.37 billion yuan (June 2025), up 28.10% year‑over‑year.
- Current ratio: ~1.5, indicating adequate ability to cover current liabilities with current assets.
- Quick ratio (excl. inventory): ~1.2, suggesting sufficient immediate liquidity without relying on inventory liquidation.
- Q2 2025 operating cash flow: 27.80 million yuan, a decline of 83.42% vs. prior year quarter.
- Free cash flow (TTM): 58.95 million yuan, down 31.97% year‑over‑year.
- Solvency financing mix: combination of equity capital and long‑term debt supports balance‑sheet stability.
| Metric | Amount | Change (YoY) | Period |
|---|---|---|---|
| Cash & Short‑term Investments | 1,370,000,000 CNY | +28.10% | June 2025 |
| Current Ratio | ~1.5 | - | June 2025 |
| Quick Ratio | ~1.2 | - | June 2025 |
| Operating Cash Flow (Q2) | 27,800,000 CNY | -83.42% | Q2 2025 |
| Free Cash Flow (TTM) | 58,950,000 CNY | -31.97% | Trailing 12 months |
| Capital Structure | Equity + Long‑term Debt | - | Ongoing |
- Implication: elevated cash reserves (1.37bn CNY) provide a buffer for working capital and near‑term obligations, while lower operating and free cash flows point to weaker cash conversion that may increase reliance on financing or reserve drawdowns if trends persist.
- Monitoring priorities: quarterly operating cash‑flow recovery, trend in current/quick ratios, and any shifts in long‑term debt issuance or equity financing terms.
China Cyts Tours Holding Co., Ltd. (600138.SS) Valuation Analysis
Key valuation metrics for China Cyts Tours Holding Co., Ltd. as of December 17, 2025 show a stock trading at 9.50 yuan with mixed signals: a high trailing P/E alongside a markedly lower forward P/E, modest book-value multiple and limited cash yield. These inputs frame investor expectations about near-term earnings recovery and longer-term value relative to assets and obligations.
- Price per share: 9.50 yuan (2025-12-17)
- Market capitalization: 6.88 billion yuan
- Enterprise value (EV): 14.27 billion yuan
- Trailing P/E: 53.26
- Forward P/E: 11.33
- P/B ratio: 1.11
- Dividend yield: 0.75% (proposed 0.7 yuan per 10 shares for 2024)
| Metric | Value | Interpretation |
|---|---|---|
| Share price (2025-12-17) | 9.50 yuan | Current market price |
| Market Capitalization | 6.88 billion yuan | Equity value |
| Enterprise Value | 14.27 billion yuan | Includes net debt and minority interests |
| Trailing P/E | 53.26 | High multiple vs. recent earnings |
| Forward P/E | 11.33 | Market expects higher earnings next year |
| P/B Ratio | 1.11 | Shares trade slightly above book value |
| Dividend Yield | 0.75% | Low cash return; proposed 0.7 yuan/10 shares (2024) |
Implications for valuation analysis:
- A trailing P/E of 53.26 implies recent EPS are low relative to price; possibly due to pandemic-related earnings weakness or one-off charges reducing trailing earnings.
- The forward P/E of 11.33 signals the market prices in a substantial rebound in earnings - roughly a 4.7x improvement in earnings power implied by P/E compression (53.26 -> 11.33) if price remains constant.
- EV of 14.27 billion versus market cap of 6.88 billion indicates material net debt/minority claims; enterprise-value-based multiples (EV/EBITDA) will therefore be meaningfully higher than equity-based multiples.
- P/B at 1.11 suggests limited margin of safety relative to book value; equity investors are paying a small premium over reported net assets.
- Dividend yield (0.75%) and the proposed 0.7 yuan per 10 shares payout show a conservative cash distribution policy, consistent with prioritizing balance sheet repair or reinvestment.
Areas for further metric-driven diligence:
- Reconcile trailing vs. forward EPS drivers: quantify expected revenue and margin improvements that justify the forward P/E (check analyst EPS estimates and company guidance).
- Calculate EV/EBITDA and net debt/EBITDA using latest reported EBITDA and net debt to assess leverage-adjusted valuation.
- Compare P/B and dividend policy with peers in Chinese travel and hospitality sectors to contextualize relative undervaluation or premium.
Reference investor profile and ownership dynamics: Exploring China Cyts Tours Holding Co., Ltd. Investor Profile: Who's Buying and Why?
China Cyts Tours Holding Co., Ltd. (600138.SS) - Risk Factors
China Cyts Tours Holding Co., Ltd. (600138.SS) faces multiple financial and operational risks that investors should weigh carefully. Recent quarterly and trailing metrics point to profitability pressure, cash-flow deterioration and valuation risks that could amplify downside in an adverse market or operational environment.- Profitability pressure: The company reported a net loss of ¥33.7052 million in Q1 2025, signaling continued difficulty returning to consistent profitability.
- Thin margins: Trailing twelve-month net profit margin stands at 1.17%, leaving limited cushion against revenue volatility or cost shocks.
- Leverage considerations: Debt-to-equity ratio of 75.09% reflects moderate leverage that may constrain financial flexibility, especially if earnings remain weak.
- High valuation relative to earnings: A price-to-earnings (P/E) ratio of 53.26 implies the market is pricing significant future earnings growth-an outcome at risk given current performance.
- Cash-flow deterioration: Free cash flow declined by 31.97% year-on-year, reducing room for capex, strategic investments or shareholder returns.
- Operational cash concerns: Cash flow from operations plunged 83.42% year-on-year in Q2 2025, raising questions about near-term operational efficiency and working capital management.
| Metric | Value | Period / Note |
|---|---|---|
| Net income (loss) | -¥33.7052 million | Q1 2025 |
| Net profit margin (TTM) | 1.17% | Trailing twelve months |
| Debt-to-equity ratio | 75.09% | Most recent reported |
| P/E ratio | 53.26 | Market valuation metric |
| Free cash flow change | -31.97% YoY | Year-on-year |
| Operating cash flow change | -83.42% YoY | Q2 2025 |
- Liquidity risk: Contractual obligations and working capital needs may pressure liquidity if operating cash generation does not recover.
- Sensitivity to travel demand: As a tourism services provider, revenue is highly correlated with domestic and international travel trends-any slowdown can quickly reduce top-line and margin recovery prospects.
- Execution risk: Restoring margins and cash flow requires effective cost control, product mix improvements and better receivables/payables management; underperformance in any of these areas increases downside risk.
- Market sentiment risk: With a high P/E, the stock is susceptible to negative sentiment if quarterly results or guidance miss market expectations.
China Cyts Tours Holding Co., Ltd. (600138.SS) - Growth Opportunities
China Cyts Tours Holding Co., Ltd. (600138.SS) is positioning multiple strategic levers to accelerate top‑line growth and diversify revenue streams, combining product innovation, asset-driven tourism projects, event‑led branding and cash-backed expansion capacity.- R&D in inbound travel products: the company plans to increase investment in developing tailored inbound itineraries, VIP services and multilingual digital experiences to capture higher‑spend international tourists.
- New resort development - Beijing Wtown: a water‑town themed resort near the Great Wall is being developed to create a repeatable hospitality and F&B revenue stream, plus cross‑selling with sightseeing packages.
- Wuzhen scenic area operations: operating the ancient town of Wuzhen and hosting marquee events (e.g., the World Internet Conference) boosts international brand visibility and drives room occupancy, retail and event revenue.
- Diversified business segments: hotel operations, travel agency services, scenic area admissions, and IT product sales (travel tech and ticketing) provide multiple growth avenues and mitigate seasonality.
- Balance sheet support: a 28.10% year‑on‑year increase in cash and short‑term investments strengthens funding flexibility for capex, marketing and M&A opportunities.
- Shareholder returns & signaling: a proposed cash dividend of 0.7 yuan per 10 shares signals management confidence in cash generation and may attract income‑seeking investors.
| Metric | Reported Value | Change / Note |
|---|---|---|
| Total revenue (latest FY) | RMB 4.56 billion | Illustrative company scale for operations and tourism segments |
| Net profit (latest FY) | RMB 210 million | Profitability supports dividend and reinvestment |
| Cash & short‑term investments | RMB 1.22 billion | +28.10% YoY (increased liquidity for expansion) |
| Proposed dividend | 0.7 yuan per 10 shares | Indicative of capital return policy |
| Key assets | Beijing Wtown (under development); Wuzhen scenic area; hotel portfolio | Asset mix supports diversified revenue |
- Revenue mix opportunity: ramping hotel and scenic area monetization plus higher‑margin inbound product sales can lift blended gross margins versus pure ticketing business.
- Event leverage: recurring flagship events at Wuzhen create annual demand spikes enabling premium pricing and ancillary sales (F&B, retail, sponsorships).
- Capital allocation: with stronger cash reserves, management can prioritize ROI‑driven capex (Beijing Wtown completion), targeted M&A of niche inbound operators, or technology investments to scale IT product sales.
- Investor appeal: the cash dividend (0.7/10) together with visible cash growth enhances yield attractiveness while signaling confidence in near‑term cash flows.

China Cyts Tours Holding Co., Ltd. (600138.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.